← Latest papers
📄 molecular biology

XRN1-dependent RNA homeostasis regulates hepatitis D virus

This study identifies the 5'-3' exoribonuclease XRN1 as a critical regulator of hepatitis D virus replication by maintaining RNA homeostasis, where its loss triggers dsRNA accumulation and innate immune activation that restricts the virus through newly discovered interferon-stimulated effectors DUSP5 and SIRPA.

Original authors: Tsukuda, S., Boutasbih, M., Wing, P. A. C., Fedorov, A., Zhu, X., Rehwinkel, J., Balfe, P., McKeating, J. A.

Published 2026-11-02
📖 5 min read🧠 Deep dive

Original authors: Tsukuda, S., Boutasbih, M., Wing, P. A. C., Fedorov, A., Zhu, X., Rehwinkel, J., Balfe, P., McKeating, J. A.

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

Viruses are masters of disguise, slipping into our cells and hijacking their machinery to make copies of themselves. Our bodies have evolved a sophisticated alarm system to detect these invaders. When a cell senses the strange, double-stranded genetic material that many viruses leave behind, it sounds the alarm, releasing chemical signals called interferons. These signals tell neighboring cells to lock down and produce a suite of antiviral proteins designed to stop the infection. However, this system must be precise; if it fires too often or too loudly, it can damage the body's own tissues or trigger autoimmune diseases. The cell therefore relies on a constant cleanup crew to manage its internal genetic environment, breaking down old or unnecessary RNA strands before they can be mistaken for a viral threat. This delicate balance between cleaning up cellular debris and sounding the alarm is central to how our bodies fight infection, yet for some viruses, the rules of engagement remain a mystery.

One such mystery surrounds the hepatitis D virus, a small but dangerous pathogen that causes the most severe form of viral hepatitis. This virus cannot survive on its own; it requires the presence of the hepatitis B virus to assemble and spread. Despite triggering a strong immune response, the hepatitis D virus often persists, and the specific mechanisms that limit its replication inside liver cells are not well understood. Researchers have long known that the virus activates the cell's sensors, but these defenses seem to have a limited impact on stopping the virus in real-world infections. A team of scientists set out to uncover why this immune response is so ineffective and to find the specific cellular factors that might be holding the virus back.

The researchers focused their investigation on a cellular enzyme called XRN1, which acts as a janitor for RNA, breaking down genetic strands that are no longer needed. They began by studying liver cells in the laboratory that had been genetically modified to lack this enzyme. Without XRN1 to clean up, these cells began to accumulate double-stranded RNA, a type of genetic material that the cell's immune sensors are programmed to recognize as a sign of viral invasion. As these stray strands piled up, the cells' internal alarms went off. The sensors, specifically proteins named MDA5 and PKR, detected the accumulation and triggered a cascade of events, leading to the production of interferons and a broad array of antiviral genes. The result was a cell that was in a constant state of high alert, effectively shutting down the ability of the hepatitis D virus to replicate.

To confirm that this immune activation was the cause of the viral suppression, the scientists introduced a chemical inhibitor that blocked the interferon signaling pathway. When they did this, the antiviral defenses in the XRN1-deficient cells quieted down, and the hepatitis D virus was able to replicate again, just as it did in normal cells. This proved that the virus was not being stopped by the lack of the cleaning enzyme itself, but by the powerful immune response that the enzyme's absence had accidentally triggered. The researchers also checked if this effect applied to other viruses. They infected the same cells with influenza, SARS-CoV-2, and other common RNA viruses. Surprisingly, the lack of XRN1 had almost no effect on these other viruses, showing that the immune response generated in this specific way was uniquely effective against hepatitis D.

The study also revealed a fascinating side effect of the enzyme's absence. The cell has another mechanism to handle double-stranded RNA, involving an enzyme called ADAR1, which chemically alters the genetic code to make the strands look less like a threat. In the cells without XRN1, the researchers observed a significant increase in this editing activity. This change affected the hepatitis D virus directly, altering a specific stop signal in its genetic code. This alteration forced the virus to produce a different version of its main protein, one that is essential for building new virus particles but which also slows down the virus's own replication cycle. The cell had essentially turned the virus's own machinery against it, creating a double layer of defense.

Finally, the team sought to identify the specific weapons the cell was using to fight the virus. By analyzing the genes that were turned on in the XRN1-deficient cells and testing them one by one, they discovered two previously unknown antiviral factors. These were proteins named DUSP5 and SIRPA. When the researchers silenced these two proteins in the cells, the virus was able to replicate more freely, even in the presence of the activated immune system. This finding suggests that DUSP5 and SIRPA are the direct agents that restrict the virus, acting as the final executioners in the immune response. The study concludes that the cellular cleanup crew, XRN1, normally keeps the immune system in check by removing stray genetic material. When this cleanup fails, the resulting buildup of debris triggers a specific, potent defense that includes these newly identified proteins, offering a potential new path for treating chronic hepatitis D by selectively activating these natural barriers.

Drowning in papers in your field?

Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.

Try Digest →